Article ID Journal Published Year Pages File Type
8235003 International Journal of Radiation Oncology*Biology*Physics 2009 6 Pages PDF
Abstract
WBRT with concurrent erlotinib is well tolerated in patients with brain metastases from non-small-cell lung cancer. The suggestion of a high intracranial disease control rate warrants additional study.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Phase I Study of Concurrent Whole Brain Radiotherapy and Erlotinib for Multiple Brain Metastases From Non-Small-Cell Lung Cancer
Authors
, , , , , , , ,